Cytokine Inhibition in Chronic Fatigue Syndrome Patients
NCT02108210
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Chronic Fatigue Syndrome
Interventions
DRUG:
Anakinra
DRUG:
Placebo
Sponsor
Radboud University Medical Center